Abstract. An understanding of the mechanisms of drug diffusion and uptake through cellular membranes is critical for elucidating drug action and in the development of effective drug delivery systems. We study these processes for emodin, a potential anticancer drug, in live cancer cells using surface-enhanced Raman scattering. Micrometersized silica beads covered by nanosized silver colloids are passively embedded into the cell and used as sensors of the drug. We demonstrate that the technique offers distinct advantages: the possibility to study the kinetics of drug diffusion through the cellular membrane toward specific cell organelles, the detection of lower drug concentrations compared to fluorescence techniques, and less damage imparted on the cell.
Introduction
The monitoring of drug diffusion into a cell plays an important role for cell membrane characterization as well as providing an understanding of how drug molecules pass through the phospholipidic bilayer. Surface-enhanced Raman scattering ͑SERS͒ is a powerful spectroscopic technique that combines high sensitivity with structural information. The SERS phenomena originates from localized surface plasmon resonances of nanoscopically textured metal structures that lead to large enhancement of Raman scattering fields. This phenomena has the potential of obtaining strong Raman signals from microscopic or even single molecule quantities of analyte. 1 The dominant mechanism is an electromagnetic effect that is due to coupling between the Raman field and optically excited surface plasmon resonances in the metal. Thus, SERS is highly dependent on surface plasmon characteristics such as the decay range, which is a few to tens of nanometers from the metal surface. 2 A secondary contribution to SERS comes from a chemical mechanism where the probed molecule is adsorbed and thus coupled electronically to the metal nanostructure surface, which leads to a resonance Raman-like enhancement. 1 The important characteristic of a SERS structure is nanosized features that lead to high localization of the excited fields. This can be seen in a variety of forms from an ordered array of nanosize objects to amorphous nanostructures such as silver colloids from citrate reduction.
SERS was previously applied effectively in the study of drug diffusion through artificial membranes. 4 SERS and surface-enhanced resonance Raman spectroscopy ͑SERRS͒ were used to study diffusion through silastic 5 ͑polydimethyl-siloxane͒ and planar palmitoyloleoylphosphatidylcholine ͑POPC͒ monolayers and bilayers, which were employed as membrane models. 6, 7 In the first case, metal colloid particles were placed under the silastic membrane. In the case of POPC monolayers and bilayers, SERRS was used to study the interaction of pirarubicin with an artificial membrane, where the membrane was transferred by a Langmuir-Blodgett technique onto a prism coated with silver.
A more complicated problem is the detection of drug diffusion through a live cellular membrane. Previously, distribution patterns for anticancer agents 8 and photodynamic therapy ͑PDT͒ drugs 9 were studied using conventional Raman spectroscopy. The SERS technique has also been used for the study of drug diffusion through live cell membranes where gold and silver metal nanoparticles ͑usually prepared by the methods in Refs. 10 and 11͒ were passively implanted inside cells and the SERS signals from molecular tags and cell compartments were detected. 12, 13 However, the use of metal colloids does not enable one to achieve good spatial resolution in the drug distribution due to the inconsistent placement of the colloids in the studied cell. This is why the fabrication of new SERS probes for in vivo applications 14 has become a very interesting field for intracellular diagnosis.
We use SERS probes, which are micrometer-sized dielectric beads partially covered by nanosized metal colloid particles, to monitor the diffusion of drugs through the membrane of live cancer cells. We show an increased sensitivity of this method in comparison to classical fluorescence techniques. The drug chosen for this study is emodin due to its potential as an anticancer PDT drug. Emodin ͑6-methyl-1,3,8-trihydroxyanthraquinone͒ is a naturally occurring anthraquinone extracted from the roots and bark of numerous plants of the genus Rhamnus. 15, 16 Previous studies have reported on the antitumoral activity of emodin against certain types of cancers. This action could take place through the inhibition of protein kinase C, protein-tyrosine kinase, 17 and also through the mitochondrial 18, 19 and membrane lipid raftassociated integrin signaling pathways. 20 Thus, an improved method for monitoring the emodin diffusion through the cell membrane is important in light of these studies and can provide information concerning its metabolic pathways from outside to inside the cell.
In our experiments, the probes were passively embedded in U87-MG cancer cells through overnight incubation, and due to their micrometer size were assumed to be in contact with the membrane. The SERS signal from the probe depends on the number of molecules that have diffused through the membrane and onto or within close proximity of the metal surfaces. Thus, the Raman signature of the drug can be measured at different times by successive acquisitions of the molecules' Raman spectra enhanced due to the presence of the probe. Because of their high sensitivity, the probes can be used not only for the detection of drug diffusion through the cellular membrane, but also for monitoring the cellular uptake of these drugs in individual cells. For a typical cellular uptake study, mainly two fluorescence spectroscopy methods are used: fluorescence spectroscopy and flow cytometry. 21 For fluorescence methods, the minimal drug concentration that can be detected is rather high because of the requirement to overcome the autofluorescence of the cell system. In flow cytometry, the cell population is treated as an ensemble, giving only average values without specificity to cell compartments. In this paper, the results from the SERS probes are compared with a fluorescence spectroscopy study of the uptake of emodin in the same cell line to demonstrate the feasibility of the SERS probes.
Experimental Section

Materials
Emodin ͑6-methyl-1,3,8-trihydroxyanthraquinone͒, dimethylsulfoxide ͑DMSO͒, 3-aminopropyl trimethoxysilane ͑APTMS͒, silver nitrate ͑AgNO 3 ͒, trisodium citrate ͑Na 3 C 6 H 5 O 7 .2H 2 O͒, sodium dodecyl sulfate ͑SDS͒, phosphate-buffered saline ͑PBS͒ ͑pH= 7.4͒, and ethanol ͑CH 3 CH 2 OH͒ were obtained from Sigma-Aldrich. The emodin stock solution was prepared in 100% DMSO. Dulbecco's modified eagle medium ͑DMEM͒, fetal bovin serum ͑FBS͒, trypsin/EDTA, penicillin, and streptomycin were purchased from Gibco, Invitrogen ͑United Kingdom͒. The 2-m SiO 2 silica beads were purchased from Micro Particles GmbH ͑Germany͒. The aqueous solutions were prepared using deionized water.
Silver-Covered SiO 2 Silica Beads
Silver colloids were prepared by reduction of silver nitrate by citrate, according to the method described in Ref. 10 . Absorption spectra of colloids were characterized between 250 and 750 nm using a UV-visible Perkin Elmer Lambda 950 spectrophotometer with 1-nm resolution. Surface-assembled monolayer modification of the silica beads was achieved by slight modification of the method proposed in Ref. 22 . Previously, we studied the production of these probes with a complete discussion of the critical parameters in the protocol. 23 Briefly, beads of 2 m size were dried overnight at 60°C and redispersed in 500 ml of anhydrous ethanol. The beads react with the APTMS solution ͑0.1% v/v͒ in ethanol for 24 h at room temperature with continuous movement. At this stage, the solution was purified by centrifuging three times at 3500 rpm using distilled ethanol and discarding the supernatant. The remaining pellet was further dried slowly at 60°C before redispersing in distilled water. Silica beads modified with amino groups were thus obtained. The silver-coated silica beads were prepared in 1 ml volumes by continuous agitation of the silver colloids and adding the APTMSmodified silica beads. Finally, homogenous silver-coated silica beads were obtained and could be tuned to a range of colloid packing densities on the surfaces.
Cells
U-87 MG human glioma cells were cultured as monolayer and were grown in DMEM containing L-glutamine ͑862 mg/ l͒, sodium pyruvate ͑110 mg/ l͒ and glucose ͑4500 mg/ l͒, supplemented with 10% FBS, penicillin ͑50 g / ml͒, and streptomycin ͑50 g / ml͒. The cells are maintained at 37°C in a humidified 5% CO 2 atmosphere between experiments. For all measurements, the cells were plated in plastic petri dishes ͑35ϫ 10 mm͒ with #0 cover glasses on the bottom at an optimal density of 5 ϫ 10 5 cells/ ml. During the measurements, the cells were enclosed in an incubator system ͑Live Cell Instrument͒ mounted on the microscope and maintained at 37°C in a humidified 5% CO 2 atmosphere. Figure 1 shows the experimental setup, including an illustration of the embedment and excitation of the probe in the cell. The samples were placed in an inverted microscope ͑Olym-pus͒. The Raman excitation was done with a 785-nm optical beam from a laser ͑MicroLaser͒ focused through a 100 ϫ 1.3 numerical aperture ͑NA͒ oil immersion objective ͑Ni-kon͒ at a power of 10 mW at the sample. The backscattered light was collected by the objective and after a notch filter it passed through a confocal system with a 100-m pinhole to a spectrometer. The spectrometer ͑Acton Research͒ had a 600 lines/ mm grating and was fitted with a thermoelectrically controlled CCD ͑Princeton Instruments͒, cooled to −80°C. A video camera provided optical images during experiments. We verified that the probe is embedded in the cell rather than stuck on the top of the membrane or to the coverslip with the cell on top, by changing the focal plane of the microscope and visually checking the position of the focused image of the membrane relative to that of the probe.
Raman Spectroscopy
The data from the CCD was proceeded using WinSpec software ͑Princeton Instruments͒. For all spectra, a five-point adjacent average smoothing was applied and the background was removed using an established method. 24 Figure 2 presents an illustration depicting the emodindiffusion-monitoring experiments with the SERS probes following two protocols. The cells were incubated during the night ͑t 0 ͒ before the experiment with a fresh culture medium containing the probes.
Raman Measurement Protocols
For the primary measurement ͓Fig. 2͑a͔͒, the media of all the samples was replaced with media containing emodin at a 2 M concentration. At a given emodin diffusion time ͑t D ͒, a petri dish of cells was removed from the incubator and rewashed three times with fresh media to remove the excess emodin ͑emodin that had not diffused into the cell͒. The cells were then placed in the microscope and the Raman spectra of the probes was recorded. Raman spectra from the probes in six different cells were collected at each elapsed incubation time. This procedure was repeated 5 times, resulting in a total of 30 cells sampled and averaged to produce a single spectrum for each elapsed time. All spectra were collected with a 50-s acquisition time at a spectral resolution of 3 cm −1 .
A secondary measurement was conducted to resolve better the 0-to 23-min range of the diffusion process ͓Fig. 2͑b͔͒. Consecutive acquisitions were made every 50 s from the same SERS probe in a cell after adding a drop of the stock emodin solution such that the final concentration was again 2 M. This was repeated 5 times and the spectra were averaged as described before. For all measurements, only the probes that were far from the nucleus, i.e., where the depth of the cell is a few micrometers, were chosen ͓see Fig. 4͑b͒ inset in Sec. 4͔ to be sure that the probe was in contact with the membrane.
Fluorescence Spectroscopy
Emodin in the cell lysate was placed in a quartz cuvette and the fluorescence was measured using a SHIMADZU RF-5301 PC spectrofluorometer with a xenon lamp light source coupled to a monochromator. The signal was detected at 90 deg to the excitation path. The experiments were carried out at a room temperature and were repeated three times. Three separate spectra were collected at excitation wavelengths corresponding to the three main absorption bands of emodin: 440, 488, and 532 nm ͑Ref. 25͒. The peak intensity value from each emission curve was used as the data point for the diffusion curve at the specific emodin incubation time.
Fluorescence Measurement Protocol
The changes in protocol were the absence of the SERS probes in the solutions and using an emodin concentration of 20 M.
The higher concentration was necessary to obtain a drug fluorescence signal higher than the autofluorescence of the cell.
After an incubation time, the cells were washed with PBS ͑pH 7.4͒, treated with trypsin/EDTA, harvested, and then centrifuged for 15 min at 1200 rpm. Then the cells were ruptured with 5% SDS solution and subsequently diluted in 100% DMSO ͑final percentage 90%͒ before transferring to a cuvette for measurements.
Results
To determine appropriate Raman bands that could act as markers of emodin, measurements of two control cases were performed where the probe was in emodin solution ͑2 M͒ and in the cell in the absence of emodin. Figure 3 compares these two control spectra to a typical Raman spectrum of the cell with probe after a long emodin diffusion time. All spectra in Fig. 3 were recorded with the same acquisition time. A significant number of background peaks appear in agreement in all spectra. We attributed most of these peaks to come from the presence of silane that is on the surface of the probe that are similarly enhanced through SERS ͑Ref. 23͒. Due to the low concentrations of emodin ͑10 −5 to 10 −7 M͒ used, the drug SERS peaks are expected to be weaker than those from the surface groups on the probe that are used to attach the metal colloids, which are constantly within the enhancing fields. The marker bands are identified to be 1170 and 1332 cm −1 ͓Fig. 3͑b͒ and 3͑c͔͒. Figure 4͑a͒ presents the emodin diffusion tracking during a 4-h period. The intenisty values from the identified marker bands are used as the data points for the diffusion curve at each emodin incubation time.
We included the standard error, defined as the standard deviation divided by the square root of the number of cells tested, which is the appropriate measure when presenting mean values. The repeated measurement for the short time range ͑0 to 23 min͒ is given in Fig. 4͑b͒ for the 1332-cm −1 marker band only.
To compare these Raman results to a standard technique, the results of the fluorescence spectroscopy uptake measurement, with 20 M emodin concentration, are presented in Fig. 5 . Figure 5͑a͒ presents typical emission spectra from the cell lysate solution at the three excitation wavelengths that correspond to emodin absorption bands. The highest intensity bands are chosen as the markers for the diffusion curves, which are given in Fig. 5͑b͒. 
Discussion
Probe Characterization
The combination and improvement of previous chemical techniques allowed for a new robust method for producing the SERS probes. An important feature is the ability to attach any type of metal, both in size and type, to the silica beads, at almost any density on the surface. 23 The passive embedment of micrometer-sized dielectric spheres in live cells, through incubation times of the order of hours, was previously reported and attributed to phagocytosis. [26] [27] [28] The process is a specific form of endocytosis where larger particles are encapsulated by the cell membrane before the membrane reforms around the particle to transfer it inside. This differs from the usual entry of small particles through typical diffusive or porous pathways through the membrane. The ability to passively embed micrometer-sized latex and silica beads in live cells Fig. 5 Monitoring emodin uptake with fluorescence spectroscopy: ͑a͒ fluorescence spectra of emodin ͑20 M͒ dissolved in the cell lysate to indicate the peak wavelengths to be used as markers at each excitation wavelength ͑440 nm, line 1; 488 nm, line 2; and 532 nm, line 3͒, and ͑b͒ cellular emodin uptake measured by monitoring the intensity maxima of the highest peak from each of the three excitations: 509 ͑circles͒, 517 ͑squares͒, and 600 nm ͑triangles͒.
was previously demonstrated. 28 Most importantly, cells similar to the ones studied here have proven to remain viable after incubation and the consequent embedment of numerous micrometer-sized beads. Finally, metal colloids were previously used for SERS studies of live cells and the silver nanostructures were not observed to be toxic to the cell. 13 Using the nanosized metal particles alone will still give SERS, however, it is difficult to locate their exact position in the cell. In particular for membrane diffusion studies, it is nearly impossible to determine exactly where the nanoparticle is in relation to the membrane. The anchoring of the metal particles to a larger bead of known size enables one to be sure of their membrane contact by observing the relative distance between the bead surface and the membrane in the focal plane of the imaging system.
The determination of appropriate marker bands for the drug is crucial because the dense vibrational spectrum of a cell increases the likelihood of the cell and drug containing common Raman modes. As seen in Fig. 3 , the emodin spectrum clearly differentiates from that of the cell at two peak positions: 1170 and 1332 cm −1 . The positions of these two bands agree with previous studies of SERS of emodin in silver colloid solution 25 and have been well characterized. 29 Bands that are in the vicinity of 1170 cm −1 are thought to originate from OH, CH 3 , and CH bending motions. This band, in particular, appears in SERS spectra that are excited off resonance, i.e., in the case of our colloids in the near-IR region. Thus, it most likely involves an in-plane CH bending, which is typically insensitive to resonant excitation. The 1332 cm −1 band lies in the region of highest intensities for SERS of emodin that originates from in-plane ring stretching modes. 29 The enhancement level of these citrate-reduced silver colloids was noted 3 to lie in the range of 10 6 to 10 7 . However, the Raman spectrum of emodin is weak to nonexistent at standard concentrations in aqueous solutions and in solid form due to the molecules' high affinity to aggregate. Thus, the molecule typically must be dispersed at very low concentrations to retain its symmetry-dictated properties, such as those that allow the Raman activity, which makes SERS a necessary condition to obtain a measurable Raman spectrum from emodin. 30 Additionally, SERS activity must be present to obtain reasonable spectra at short acquisition times and with the extremely minute drug concentrations that are naturally present in the cell. This latter point is quite clear in Fig. 3 in light of the large number of background peaks that are mostly attributed to the surface chemistry of the probe. Determining an enhancement factor for the colloids with emodin is not possible because of the inability to obtain a normal Raman spectra from emodin in the absence of metal.
When using these probes, one must also consider the variation of enhancement from probe to probe. This could be due to varying amounts of metal on the surface as well as the size uniformity of the colloids. To counter this, we normalized each spectrum to the intensity of the 1118 cm −1 band, which comes from the APTMS chemical that created the amino group coverage on the probe surface. 23, 25 The size of the silica bead and the APTMS coverage on the surface are identical between probes, therefore the intensity of the enhanced Raman band for this material can be used as a relative estimate of the level of probe-induced enhancement.
Comparison of SERS and Fluorescence Diffusion Monitoring
In the standard fluorescence measurement, the concept of incubating the cells with the drug, then lysing them into solution to measure the drug fluorescence emission is a wellestablished technique. 31 Consequently, the result of Fig. 5 agrees with previous results of emodin diffusion through the human intestinal Caco-2 cell. 32 The trend shows common characteristics: a high peak at short incubation time followed by an approximately constant drug concentration for later times. The initial increase of emodin molecules is attributed to its lipofilic character, which allows for the drug accumulating inside the lipidic part of the cell membrane. The decrease of emodin after the initial peak is linked to the drug being pumped out or metabolized by the cell. 32 The monitoring of emodin diffusion with the SERS probes, presented in Fig. 4 , produces a similar result. Similar to the intensity differences of the fluorescence measurements at different excitation wavelengths, the intensity values for the two marker Raman bands do not coincide. This is most likely due to the disproportionate enhancement of the Raman spectrum as a result of symmetry considerations of each vibrational mode and their coupling to the metal. However, the shapes of the two curves are quite similar and agree well with reference to the incubation time. Most important, the initial climax of emodin concentration at 15 min that was present in the fluorescence measurement, is observed in both curves once again. This is seen in Fig. 4͑a͒ and is further confirmed in the short time range result in Fig. 4͑b͒ . Due to the cell metabolism, the emodin concentration is expected to decrease to a constant level at a long incubation time, as already stated. The concentration dependence obtained with the SERS probe, however, shows a rising tail that then reaches a saturation point where the emodin concentration remains constant at long incubations times. This is possibly due to emodin accumulation in other specific cell compartments such as the mitochondria 18, 19 and lysosomes. For drug quantities localized in these areas, the probe would still be sensitive to these molecules as long as they are within the enhancement field decay range, which is typically a few to tens of nanometers. 2 We also cannot rule out the possibility of molecule accumulation on the surface of the probe itself. This could cause a rise in the SERS intensity at a slow enough rate such that only the long incubation times ͑ Ͼ 2 h͒ are affected.
Advantages of SERS Probes
The use of SERS probes for monitoring the drug diffusion through a cell membrane has been shown here to be a tool comparable to common fluorescence techniques. The action of cell lysing and testing the consequent solution in the fluorescence study is a measure of the total cell uptake of emodin. However, a similar trend is seen with the SERS probe that is a measurement of a specific point in the cell. In this paper, only probes that were in the membrane, far from the nucleus, were measured. The similarity is then reasonable when one considers that the pure membrane area makes up a large portion of the cell and is therefore the most responsible for the drug uptake. Future work entails positioning the probe with microinjection techniques to study heterogeneities of the drug diffusion through different areas of the cell. This paper has revealed a number of advantages of SERS probes over conventional fluorescence techniques for the monitoring of drug diffusion through cells. The first is that an order of magnitude less drug concentration could be used. This is important when looking into the onset of drug action in a cell. Second, the use of embedded probes evades the obvious unnatural step of cell lysing and consequent testing of cell components in solution. Aside from the fact that this enables the study of a live cell in a more realistic setting, the added benefit of the single-cell experiment is that a simultaneous combination with other forms of spectroscopy ͑fluores-cence, absorption, etc.͒ is possible. This leads to less invasive studies of a wider range of parameters under identical cell conditions. Additionally, with more refined injection techniques, the placement of the probes can be user defined, enabling real-time studies and comparisons of drug diffusions through different compartments of the cellular environment.
The prevailing disadvantage of SERS versus fluorescence, which must be considered with these probes as well, is the reproducibilty of the metal structures and the consistency of the SERS enhancement. At the onset, SERS is a more volatile optical process because it is highly sensitive to the relative orientation between the molecule and metal surface. Additionally, there are mechanisms between the electromagnetic enhancement, which can occur a short distance away from the metal surface, and the chemical enhancement, which is due to molecular adsorption to the metal, that can be competing or working in tandem, depending on the distance and orientation of the molecule from the metal surface. We found previously that the metal coverage of the SERS probes are highly reproducible and gave consistent SERS intensities for emodin in aqueous solutions. 23 However, it is still difficult to obtain consistent enhancement based on the preceding reasons. Despite our normalization procedure, based on the intensity of a Raman band from the silane monolayer of the probe, we believe these factors are strong contributers to the error bars in Fig. 4 , which are most likely larger than what would be expected from a typical live cell sample set. Nevertheless, the error at low incubation times is small and worsens at longer times ͑more than 2 h͒ making these probes suitable for short-time diffusion characteristics. The inconsistency at longer incubation times could also be due to the build up of emodin at the probe surface, which would skew the measured Raman intensity, or to altered interactions of the drug with the probe surface due to the many other particles in the intracellular medium. We are currently undertaking steps to add a second dielectric layer to cover the metal colloids, which could reduce the amount of accumulation of emodin and other cell material on the surface of the probe.
Conclusion
We demonstrated drug diffusion monitoring through a live cell membrane using SERS probes. Micrometer-sized silica beads were partially covered with silver nanocolloids that enhance the Raman signal from molecules that are close to or adsorbed on the bead surface. The probes were embedded in the cell with no perceived damage and excited with a near-IR beam. The resulting spectra show emodin diffusion trends that agree with those found using common fluorescence techniques. The initial fast diffusion is well resolved, while some discrepancies at long drug incubation times remain.
